drugset / Trial / NCT05040425

Radioprotective Effect of Chinese Herbal Medicine on Oral Mucositis

NCT05040425 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

This protocol describes a randomized, double-arm, parallel-group, open-label controlled study that aims to evaluate the efficacy of Chinese herbal medicine on head and neck cancer patients with oral mucositis toxicities and quality of life during radiotherapy.

Timeline

Start
2021-08-30
Primary completion
2022-08-17
Completion
2023-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zi-Yin-Liang-Ge-San Traditional medicine (herbal / TCM) 4 g Oral